NCT06393569 Sense of Security With Access to Palliative Outpatient Clinic
| NCT ID | NCT06393569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Skane |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-03-14 |
| Primary Completion | 2028-03-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-03-14 with a primary completion date of 2028-03-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to evaluate experience of security, accessibility, and avoidable utilization of health care services in patients who have had access to specialized palliative care clinic (SPCC) compared to those who have not, and to evaluate the relatives' experience of the care.
Eligibility Criteria
Inclusion Criteria: \- Patients admitted to included ASiH-unit Exclusion Criteria: * Patients with cognitive impairment * Patients who cannot fill in a questionnaire in Swedish, Arabic or Serbo-Croatian.
Contact & Investigator
Maria Schelin, ass.prof
PRINCIPAL INVESTIGATOR
Region Skane
Frequently Asked Questions
Who can join the NCT06393569 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06393569 currently recruiting?
Yes, NCT06393569 is actively recruiting participants. Contact the research team at sofia.persson@skane.se for enrollment information.
Where is the NCT06393569 trial being conducted?
This trial is being conducted at Lund, Sweden.
Who is sponsoring the NCT06393569 clinical trial?
NCT06393569 is sponsored by Region Skane. The principal investigator is Maria Schelin, ass.prof at Region Skane. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.